Correspondence on "ACR/EULAR antiphospholipid syndrome classification criteria" by Barbhaiya et al

被引:4
|
作者
Damoiseaux, Jan [1 ,2 ]
van Beers, Joyce [1 ]
机构
[1] Maastricht Univ, Cent Diagnost Lab, Med Ctr, Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, Maastricht, Netherlands
关键词
Antiphospholipid Syndrome; Classification; Autoantibodies;
D O I
10.1136/ard-2023-225067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:e6 / e6
页数:1
相关论文
共 50 条
  • [41] Validation of 2017 classification criteria for adult and juvenile idiopathic inflammatory myopathies proposed by EULAR/ACR in Chinese patients
    Zhang, Xiaohui
    Yang, Xinlei
    Ji, Lanlan
    Zhang, Zhuoli
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (07) : 1278 - 1282
  • [42] European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance
    Aringer, Martin
    Brinks, Ralph
    Doerner, Thomas
    Daikh, David
    Mosca, Marta
    Ramsey-Goldman, Rosalind
    Smolen, Josef S.
    Wofsy, David
    Boumpas, Dimitrios T.
    Kamen, Diane L.
    Jayne, David
    Cervera, R.
    Costedoat-Chalumeau, Nathalie
    Diamond, Betty
    Gladman, Dafna D.
    Hahn, Bevra
    Hiepe, Falk
    Jacobsen, Soren
    Khanna, Dinesh
    Lerstrom, Kirsten
    Massarotti, Elena
    McCune, Joseph
    Ruiz-Irastorza, Guillermo
    Sanchez-Guerrero, Jorge
    Schneider, Matthias
    Urowitz, Murray
    Bertsias, George
    Hoyer, Bimba F.
    Leuchten, Nicolai
    Schmajuk, Gabriela
    Tani, Chiara
    Tedeschi, Sara K.
    Touma, Zahi
    Anic, Branimir
    Assan, Florence
    Chan, Tak Mao
    Clarke, Ann Elaine
    Crow, Mary K.
    Czirjak, Laszlo
    Doria, Andrea
    Graninger, Winfried
    Halda-Kiss, Bernadett
    Hasni, Sarfaraz
    Izmirly, Peter M.
    Jung, Michelle
    Kumanovics, Gabor
    Mariette, Xavier
    Padjen, Ivan
    Pego-Reigosa, Jose M.
    Romero-Diaz, Juanita
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (06) : 775 - 781
  • [43] Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort
    Codes-Mendez, Helena
    Sainz, Luis
    Park, Hye Sang
    Corominas, Hector
    Diaz-Torne, Cesar
    RMD OPEN, 2024, 10 (02):
  • [44] Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome
    Solano, C.
    Lamuno, M.
    Vargas, A.
    Amezcua-Guerra, L. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (06) : 914 - 919
  • [46] Evaluation of the ACR/EULAR 2022 criteria for classification of ANCA-associated vasculitis in a population-based cohort from Sweden
    Rathmann, Jens
    Segelmark, Marten
    Mohammad, Aladdin J.
    RHEUMATOLOGY, 2023, : 1965 - 1972
  • [47] IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis
    Kelchtermans, H.
    Pelkmans, L.
    de Laat, B.
    Devreese, K. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (08) : 1530 - 1548
  • [48] Utility of the 2019 EULAR/ACR SLE classification criteria for predicting mortality and hospitalisation: development and cross-validation of ominosity score
    Figueroa-Parra, Gabriel
    Hanson, Andrew C.
    Sanchez-Rodriguez, Alain
    Meade-Aguilar, Jose A.
    Gonzalez-Trevino, Mariana
    Cuellar-Gutierrez, Maria C.
    Barbour, Kamil E.
    Duarte-Garcia, Ali
    Crowson, Cynthia
    RMD OPEN, 2024, 10 (04):
  • [49] Evaluation of the ACR/EULAR 2022 criteria for classification of ANCA-associated vasculitis in a population-based cohort from Sweden
    Rathmann, Jens
    Segelmark, Marten
    Mohammad, Aladdin J.
    RHEUMATOLOGY, 2023, 63 (07) : 1965 - 1972
  • [50] Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?
    Mohammad Hassan A. Noureldine
    Ali A. Haydar
    Ahmad Berjawi
    Rody Elnawar
    Ahmad Sweid
    Munther A. Khamashta
    Graham R. V. Hughes
    Imad Uthman
    Immunologic Research, 2017, 65 : 230 - 241